Pharmaceutical compounding company Fagron (EBR:FAGR) plans to combine with Humco and its portfolio of drug-delivery technology in a deal valued up to $70 million, the companies announced today.
According to the agreement, Humco chairman & CEO Gregory Pulido will become executive chairman while Andrew Pulido, Humco’s president of global pharmaceuticals, will assume the role of president.
Get the full story at our sister site, Drug Delivery Business News.
The post Fagron combines with Humco and its drug-delivery tech in $70m deal appeared first on MassDevice.